Arginase, Nitric Oxide Synthase, and Novel Inhibitors of L-arginine Metabolism in Immune Modulation

Cancer Immunotherapy: Immune Suppression and Tumor Growth: Second Edition

Volumn , Issue , 2013, Pages 597-634

  Chioda, Mariacristina ^a   Marigo, Ilaria ^b   Mandruzzato, Susanna ^c   Mocellin, Simone ^c   Bronte, Vincenzo ^d  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Arginase; L Arginine metabolism; Nitric Oxide Synthase; Peroxynitrite generation; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

EID: 84902225123     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-394296-8.00034-8     Document Type: Chapter

References (337)

1. Ahn B., Ohshima H. Suppression of Intestinal Polyposis in Apc(Min/+) Mice by Inhibiting Nitric Oxide Production. Cancer Res 2001, 61:8357-8360.
2. Albina J.E., Mahoney E.J., Daley J.M., Wesche D.E., Morris S.M., Reichner J.S. Macrophage Arginase Regulation by CCAAT/Enhancer-Binding Protein Beta. Shock 2005, 23:168-172.
3. Albina J.E., Reichner J.S. Oxygen and the Regulation of Gene Expression in Wounds. Wound Repair Regen 2003, 11:445-451.
4. Alderton W.K., Cooper C.E., Knowles R.G. Nitric Oxide Synthases: Structure, Function and Inhibition. Biochem J 2001, 357:593-615.
5. Allavena P., Mantovani A. Immunology in the Clinic Review Series; Focus on Cancer: Tumour-Associated Macrophages: Undisputed Stars of the Inflammatory Tumour Microenvironment. Clin Exp Immunol 2012, 167:195-205.
6. Ambs S., Bennett W.P., Merriam W.G., Ogunfusika M.O., Oser S.M., Khan M.A., et al. Vascular Endothelial Growth Factor and Nitric Oxide Synthase Expression in Human Lung Cancer and the Relation to p53. Br J Cancer 1998, 78:233-239.
7. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., et al. Frequent Nitric Oxide Synthase-2 Expression in Human Colon Adenomas: Implication for Tumor Angiogenesis and Colon Cancer Progression. Cancer Res 1998, 58:334-341.
8. Angelini G., Gardella S., Ardy M., Ciriolo M.R., Filomeni G., Di Trapani G., et al. Antigen-Presenting Dendritic Cells Provide the Reducing Extracellular Microenvironment Required for T Lymphocyte Activation. Proc Natl Acad Sci U S A 2002, 99:1491-1496.
9. Ash D.E. Structure and Function of Arginases. J Nutr 2004, 134:2760S-2764S. Discussion 5S-7S.
10. Aulak K.S., Miyagi M., Yan L., West K.A., Massillon D., Crabb J.W., et al. Proteomic Method Identifies Proteins Nitrated in Vivo During Inflammatory Challenge. Proc Natl Acad Sci U S A 2001, 98:12056-12061.
11. Badovinac V.P., Porter B.B., Harty J.T. Programmed Contraction of CD8(+) T Cells after Infection. Nat Immunol 2002, 3:619-626.
12. Badovinac V.P., Porter B.B., Harty J.T. CD8+ T Cell Contraction Is Controlled by Early Inflammation. Nat Immunol 2004, 5:809-817.
13. Balkwill F., Charles K.A., Mantovani A. Smoldering and Polarized Inflammation in the Initiation and Promotion of Malignant Disease. Cancer Cell 2005, 7:211-217.
14. Balkwill F., Mantovani A. Inflammation and Cancer: Back to Virchow?. Lancet 2001, 357:539-545.
15. Baniyash M. Tcr Zeta-Chain Downregulation: Curtailing an Excessive Inflammatory Immune Response. Nat Rev Immunol 2004, 4:675-687.
16. Barbul A., Lazarou S.A., Efron D.T., Wasserkrug H.L., Efron G. Arginine Enhances Wound Healing and Lymphocyte Immune Responses in Humans. Surgery 1990, 108:331-336. Discussion 6-7.
17. Barra V., Kuhn A.M., von Knethen A., Weigert A., Brune B. Apoptotic Cell-Derived Factors Induce Arginase II Expression in Murine Macrophages by Activating Erk5/Creb. Cell Mol Life Sci 2011, 68:1815-1827.
18. Bauer H., Jung T., Tsikas D., Stichtenoth D.O., Frolich J.C., Neumann C. Nitric Oxide Inhibits the Secretion of T-Helper 1- and T-Helper 2-Associated Cytokines in Activated Human T Cells. Immunology 1997, 90:205-211.
19. Bauer P.M., Fukuto J.M., Buga G.M., Pegg A.E., Ignarro L.J. Nitric Oxide Inhibits Ornithine Decarboxylase by S-Nitrosylation. Biochem Biophys Res Commun 1999, 262:355-358.
20. Bentz B.G., Haines G.K., Radosevich J.A. Increased Protein Nitrosylation in Head and Neck Squamous Cell Carcinogenesis. Head Neck 2000, 22:64-70.
21. Bergmann C., Strauss L., Zeidler R., Lang S., Whiteside T.L. Expansion of Human T Regulatory Type 1 Cells in the Microenvironment of Cyclooxygenase 2 Overexpressing Head and Neck Squamous Cell Carcinoma. Cancer Res 2007, 67:8865-8873.
22. Bing R.J., Miyataka M., Rich K.A., Hanson N., Wang X., Slosser H.D., et al. Nitric Oxide, Prostanoids, Cyclooxygenase, and Angiogenesis in Colon and Breast Cancer. Clin Cancer Res 2001, 7:3385-3392.
23. Bingisser R., Tilbrook P., Holt P., Kees U. Macrophage-Derived Nitric Oxide Regulates T-Cell Activation Via Reversible Disruption of the Jak3/Stat5 Signaling Pathway. J Immunol 1998, 160:5729-5734.
24. Blachier F., Mignon A., Soubrane O. Polyamines Inhibit Lipopolysaccharide-Induced Nitric Oxide Synthase Activity in Rat Liver Cytosol. Nitric Oxide 1997, 1:268-272.
25. Bobe P., Benihoud K., Grandjon D., Opolon P., Pritchard L.L., Huchet R. Nitric Oxide Mediation of Active Immunosuppression Associated with Graft-Versus-Host Reaction. Blood 1999, 94:1028-1037.
26. Bogdan C. Nitric Oxide and the Immune Response. Nat Immunol 2001, 2:907-916.
27. Bogdan C., Rollinghoff M., Diefenbach A. Reactive Oxygen and Reactive Nitrogen Intermediates in Innate and Specific Immunity. Curr Opin Immunol 2000, 12:64-76.
28. Bogdan C., Rollinghoff M., Diefenbach A. The Role of Nitric Oxide in Innate Immunity. Immunol Rev 2000, 173:17-26.
29. Boutard V., Havouis R., Fouqueray B., Philippe C., Moulinoux J.P., Baud L. Transforming Growth Factor-Beta Stimulates Arginase Activity in Macrophages. Implications for the Regulation of Macrophage Cytotoxicity. J Immunol 1995, 155:2077-2084.
30. Brito C., Naviliat M., Tiscornia A.C., Vuillier F., Gualco G., Dighiero G., et al. Peroxynitrite Inhibits T Lymphocyte Activation and Proliferation by Promoting Impairment of Tyrosine Phosphorylation and Peroxynitrite- Driven Apoptotic Death. J Immunol 1999, 162:3356-3366.
31. Bronte V., Kasic T., Gri G., Gallana K., Borsellino G., Marigo I., et al. Boosting Antitumor Responses of T Lymphocytes Infiltrating Human Prostate Cancers. J Exp Med 2005, 201:1257-1268.
32. Bronte V., Serafini P., De Santo C., Marigo I., Tosello V., Mazzoni A., et al. IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice. J Immunol 2003, 170:270-278.
33. Bronte V., Serafini P., Mazzoni A., Segal D.M., Zanovello P. L-Arginine Metabolism in Myeloid Cells Controls T-Lymphocyte Functions. Trends Immunol 2003, 24:302-306.
34. Bronte V., Zanovello P. Regulation of Immune Responses by L-Arginine Metabolism. Nat Rev Immunol 2005, 5:641-654.
35. Brookes P.S., Salinas E.P., Darley-Usmar K., Eiserich J.P., Freeman B.A., Darley-Usmar V.M., et al. Concentration-Dependent Effects of Nitric Oxide on Mitochondrial Permeability Transition and Cytochrome C. Release. J Biol Chem 2000, 275:20474-20479.
36. Brune B., Zhou J. The Role of Nitric Oxide (NO) in Stability Regulation of Hypoxia Inducible Factor-1alpha (HIF-1alpha). Curr Med Chem 2003, 10:845-855.
37. Buga G.M., Wei L.H., Bauer P.M., Fukuto J.M., Ignarro L.J. Ng-Hydroxy-L-Arginine and Nitric Oxide Inhibit Caco-2 Tumor Cell Proliferation by Distinct Mechanisms. Am J Physiol 1998, 275:R1256-R1264.
38. Carr A., Rodriguez E., Arango Mdel C., Camacho R., Osorio M., Gabri M., et al. Immunotherapy of Advanced Breast Cancer with a Heterophilic Ganglioside (Neugcgm3) Cancer Vaccine. J Clin Oncol 2003, 21:1015-1021.
39. Cauley L., Miller E., Yen M., Swain S. Superantigen-Induced CD4 T Cell Tolerance Mediated by Myeloid Cells and Ifn-Gamma. J Immunol 2000, 165:6056.
40. Cederbaum S.D., Yu H., Grody W.W., Kern R.M., Yoo P., Iyer R.K. Arginases I and II: Do Their Functions Overlap?. Mol Genet Metab 2004, 81(Suppl. 1):S38-S44.
41. Cerutti J.M., Latini F.R., Nakabashi C., Delcelo R., Andrade V.P., Amadei M.J., et al. Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers. Clin Cancer Res 2006, 12:3311-3318.
42. Chang C.I., Liao J.C., Kuo L. Macrophage Arginase Promotes Tumor Cell Growth and Suppresses Nitric Oxide-Mediated Tumor Cytotoxicity. Cancer Res 2001, 61:1100-1106.
43. Chang C.S., Chen W.N., Lin H.H., Wu C.C., Wang C.J. Increased Oxidative DNA Damage, Inducible Nitric Oxide Synthase, Nuclear Factor KappaB Expression and Enhanced Antiapoptosis-Related Proteins in Helicobacter Pylori-Infected Non-Cardiac Gastric Adenocarcinoma. World J Gastroenterol 2004, 10:2232-2240.
44. Chaturvedi R., de Sablet T., Coburn L.A., Gobert A.P., Wilson K.T. Arginine and Polyamines in Helicobacter Pylori-Induced Immune Dysregulation and Gastric Carcinogenesis. Amino Acids 2012, 42:627-640.
45. Chen C., Liu C.P. Regulatory Function of a Novel Population of Mouse Autoantigen-Specific Foxp3 Regulatory T Cells Depends on IFN-Gamma, NO, and Contact with Target Cells. PLoS One 2009, 4:e7863.
46. Chen Y.H., Layne M.D., Chung S.W., Ejima K., Baron R.M., Yet S.F., et al. Elk-3 Is a Transcriptional Repressor of Nitric-Oxide Synthase 2. J Biol Chem 2003, 278:39572-39577.
47. Chiarugi A., Rovida E., Dello Sbarba P., Moroni F. Tryptophan Availability Selectively Limits No-Synthase Induction in Macrophages. J Leukoc Biol 2003, 73:172-177.
48. Chin K., Kurashima Y., Ogura T., Tajiri H., Yoshida S., Esumi H. Induction of Vascular Endothelial Growth Factor by Nitric Oxide in Human Glioblastoma and Hepatocellular Carcinoma Cells. Oncogene 1997, 15:437-442.
49. Choy J.C., Wang Y., Tellides G., Pober J.S. Induction of Inducible No Synthase in Bystander Human T Cells Increases Allogeneic Responses in the Vasculature. Proc Natl Acad Sci U S A 2007, 104:1313-1318.
50. Cianchi F., Cortesini C., Fantappie O., Messerini L., Sardi I., Lasagna N., et al. Cyclooxygenase-2 Activation Mediates the Proangiogenic Effect of Nitric Oxide in Colorectal Cancer. Clin Cancer Res 2004, 10:2694-2704.
51. Cianchi F., Cortesini C., Fantappie O., Messerini L., Schiavone N., Vannacci A., et al. Inducible Nitric Oxide Synthase Expression in Human Colorectal Cancer: Correlation with Tumor Angiogenesis. Am J Pathol 2003, 162:793-801.
52. Clevers H. At the Crossroads of Inflammation and Cancer. Cell 2004, 118:671-674.
53. Cobbs C.S., Brenman J.E., Aldape K.D., Bredt D.S., Israel M.A. Expression of Nitric Oxide Synthase in Human Central Nervous System Tumors. Cancer Res 1995, 55:727-730.
54. Coleman J.W. Nitric Oxide in Immunity and Inflammation. Int Immunopharmacol 2001, 1:1397-1406.
55. Cook T., Wang Z., Alber S., Liu K., Watkins S.C., Vodovotz Y., et al. Nitric Oxide and Ionizing Radiation Synergistically Promote Apoptosis and Growth Inhibition of Cancer by Activating P53. Cancer Res 2004, 64:8015-8021.
56. Corzo C.A., Condamine T., Lu L., Cotter M.J., Youn J.I., Cheng P., et al. Hif-1alpha Regulates Function and Differentiation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. J Exp Med 2010, 207:2439-2453.
57. Coussens L.M., Werb Z. Inflammation and Cancer. Nature 2002, 420:860-867.
58. Davel L.E., Jasnis M.A., de la Torre E., Gotoh T., Diament M., Magenta G. Sacerdote de Lustig E and Sales ME. Arginine Metabolic Pathways Involved in the Modulation of Tumor-Induced Angiogenesis by Macrophages. FEBS Lett 2002, 532:216-220.
59. de Jonge W.J., Kwikkers K.L., te Velde A.A., van Deventer S.J., Nolte M.A., Mebius R.E., et al. Arginine Deficiency Affects Early B Cell Maturation and Lymphoid Organ Development in Transgenic Mice. J Clin Invest 2002, 110:1539-1548.
60. De Santo C., Serafini P., Marigo I., Dolcetti L., Bolla M., P DS Melani C, et al. Nitroaspirin Corrects Immune Dysfunction in Tumor-Bearing Hosts and Promotes Tumor Eradication by Cancer Vaccination. Proc Natl Acad Sci U S A 2005, 102:4185-4190.
61. De Santo C., Serafini P., Marigo I., Dolcetti L., Bolla M., Del Soldato P., et al. Nitroaspirin Corrects Immune Dysfunction in Tumor-Bearing Hosts and Promotes Tumor Eradication by Cancer Vaccination. Proc Natl Acad Sci U S A 2005, 102:4185-4190.
62. del Ara R.M., Gonzalez-Polo R.A., Caro A., del Amo E., Palomo L., Hernandez E., et al. Diagnostic Performance of Arginase Activity in Colorectal Cancer. Clin Exp Med 2002, 2:53-57.
63. Devadas S., Zaritskaya L., Rhee S.G., Oberley L., Williams M.S. Discrete Generation of Superoxide and Hydrogen Peroxide by T Cell Receptor Stimulation: Selective Regulation of Mitogen-Activated Protein Kinase Activation and Fas Ligand Expression. J Exp Med 2002, 195:59-70.
64. Diefenbach A., Schindler H., Rollinghoff M., Yokoyama W.M., Bogdan C. Requirement for Type 2 NO Synthase for IL-12 Signaling in Innate Immunity. Science 1999, 284:951-955.
65. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of Nitric Oxide Synthase in Endothelial Cells by Akt-Dependent Phosphorylation. Nature 1999, 399:601-605.
66. Dimmeler S., Zeiher A.M. Nitric Oxide-an Endothelial Cell Survival Factor. Cell Death Differ 1999, 6:964-968.
67. Dolcetti L., Peranzoni E., Ugel S., Marigo I., Fernandez Gomez A., Mesa C., et al. Hierarchy of Immunosuppressive Strength among Myeloid-Derived Suppressor Cell Subsets Is Determined by GM-CSF Eur J Immunol 2010, 40:22-35.
68. Dudley M.E., Wunderlich J.R., Yang J.C., Sherry R.M., Topalian S.L., Restifo N.P., et al. Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients with Refractory Metastatic Melanoma. J Clin Oncol 2005, 23:2346-2357.
69. Duhe R.J., Evans G.A., Erwin R.A., Kirken R.A., Cox G.W., Farrar W.L. Nitric Oxide and Thiol Redox Regulation of Janus Kinase Activity. Proc Natl Acad Sci U S A 1998, 95:126-131.
70. Dunn J., Gutbrod S., Webb A., Pak A., Jandu S.K., Bhunia A., et al. S-Nitrosation of Arginase 1 Requires Direct Interaction with Inducible Nitric Oxide Synthase. Mol Cell Biochem 2011, 355:83-89.
71. Ekmekcioglu S., Ellerhorst J., Smid C.M., Prieto V.G., Munsell M., Buzaid A.C., et al. Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival. Clin Cancer Res 2000, 6:4768-4775.
72. El-Gayar S., Thuring-Nahler H., Pfeilschifter J., Rollinghoff M., Bogdan C. Translational Control of Inducible Nitric Oxide Synthase by IL-13 and Arginine Availability in Inflammatory Macrophages. J Immunol 2003, 171:4561-4568.
73. El Kasmi K.C., Qualls J.E., Pesce J.T., Smith A.M., Thompson R.W., Henao-Tamayo M., et al. Toll-Like Receptor-Induced Arginase 1 in Macrophages Thwarts Effective Immunity against Intracellular Pathogens. Nat Immunol 2008, 9:1399-1406.
74. Elfering S.L., Sarkela T.M., Giulivi C. Biochemistry of Mitochondrial Nitric-Oxide Synthase. J Biol Chem 2002, 277:38079-38086.
75. Ellies L.G., Fishman M., Hardison J., Kleeman J., Maglione J.E., Manner C.K., et al. Mammary Tumor Latency Is Increased in Mice Lacking the Inducible Nitric Oxide Synthase. Int J Cancer 2003, 106:1-7.
76. Erdely A., Kepka-Lenhart D., Clark M., Zeidler-Erdely P., Poljakovic M., Calhoun W.J., et al. Inhibition of Phosphodiesterase 4 Amplifies Cytokine-Dependent Induction of Arginase in Macrophages. Am J Physiol Lung Cell Mol Physiol 2006, 290:L534-L539.
77. Felley-Bosco E. Role of Nitric Oxide in Genotoxicity: Implication for Carcinogenesis. Cancer Metastasis Rev 1998, 17:25-37.
78. + Regulatory T Cells. Eur J Immunol 2008, 38:2512-2527.
79. Fernandez A., Mesa C., Marigo I., Dolcetti L., Clavell M., Oliver L., et al. Inhibition of Tumor-Induced Myeloid-Derived Suppressor Cell Function by a Nanoparticulated Adjuvant. J Immunol 2011, 186:264-274.
80. Finke J.H., Zea A.H., Stanley J., Longo D.L., Mizoguchi H., Tubbs R.R., et al. Loss of T-Cell Receptor Zeta Chain and P56lck in T-Cells Infiltrating Human Renal Cell Carcinoma. Cancer Res. 1993, 53:5613-5616.
81. Fischer T.A., Palmetshofer A., Gambaryan S., Butt E., Jassoy C., Walter U., et al. Activation of Cgmp-Dependent Protein Kinase Ibeta Inhibits Interleukin 2 Release and Proliferation of T Cell Receptor-Stimulated Human Peripheral T Cells. J Biol Chem 2001, 276:5967-5974.
82. Fligger J., Blum J., Jungi T.W. Induction of Intracellular Arginase Activity Does Not Diminish the Capacity of Macrophages to Produce Nitric Oxide in Vitro. Immunobiology 1999, 200:169-186.
83. Forstermann U., Boissel J.P., Kleinert H. Expressional Control of the Constitutive Isoforms of Nitric Oxide Synthase (Nos I and Nos III). FASEB J 1998, 12:773-790.
84. Gabri M.R., Mazorra Z., Ripoll G.V., Mesa C., Fernandez L.E., Gomez D.E., et al. Complete Antitumor Protection by Perioperative Immunization with GM3/VSSP Vaccine in a Preclinical Mouse Melanoma Model. Clin Cancer Res 2006, 12:7092-7098.
85. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated Regulation of Myeloid Cells by Tumours. Nat Rev Immunol 2012, 12:253-268.
86. Gallardo-Soler A., Gomez-Nieto C., Campo M.L., Marathe C., Tontonoz P., Castrillo A., et al. Arginase I Induction by Modified Lipoproteins in Macrophages: A Peroxisome Proliferator-Activated Receptor-Gamma/Delta-Mediated Effect That Links Lipid Metabolism and Immunity. Mol Endocrinol 2008, 22:1394-1402.
87. + T Cells. J Clin Invest 2006, 116:2777-2790.
88. Gallo O., Masini E., Morbidelli L., Franchi A., Fini-Storchi I., Vergari W.A., et al. Role of Nitric Oxide in Angiogenesis and Tumor Progression in Head and Neck Cancer. J Natl Cancer Inst 1998, 90:587-596.
89. Gannon P.O., Godin-Ethier J., Hassler M., Delvoye N., Aversa M., Poisson A.O., et al. Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer. PLoS One 2010, 5:e12107.
90. Gobert A.P., McGee D.J., Akhtar M., Mendz G.L., Newton J.C., Cheng Y., et al. Helicobacter Pylori Arginase Inhibits Nitric Oxide Production by Eukaryotic Cells: A Strategy for Bacterial Survival. Proc Natl Acad Sci U S A 2001, 98:13844-13849.
91. Goni O., Alcaide P., Fresno M. Immunosuppression During Acute Trypanosoma Cruzi Infection: Involvement of Ly6G (Gr1(+))Cd11b(+) Immature Myeloid Suppressor Cells. Int Immunol 2002, 14:1125-1134.
92. Gordon S. Alternative Activation of Macrophages. Nat Rev Immunol 2003, 3:23-35.
93. Gotoh T., Chowdhury S., Takiguchi M., Mori M. The Glucocorticoid-Responsive Gene Cascade. Activation of the Rat Arginase Gene through Induction of C/EBPbeta. J Biol Chem 1997, 272:3694-3698.
94. Grandvaux N., Gaboriau F., Harris J., tenOever B.R., Lin R., Hiscott J. Regulation of Arginase Ii by Interferon Regulatory Factor 3 and the Involvement of Polyamines in the Antiviral Response. FEBS J 2005, 272:3120-3131.
95. Gratton J.P., Lin M.I., Yu J., Weiss E.D., Jiang Z.L., Fairchild T.A., et al. Selective Inhibition of Tumor Microvascular Permeability by Cavtratin Blocks Tumor Progression in Mice. Cancer Cell 2003, 4:31-39.
96. Gray M.J., Poljakovic M., Kepka-Lenhart D., Morris S.M. Induction of Arginase I Transcription by IL-4 Requires a Composite DNA Response Element for STAT6 and C/Ebpbeta. Gene 2005, 353:98-106.
97. Grimm E.A., Ellerhorst J., Tang C.-H., Ekmekcioglu S. Constitutive Intracellular Production of Inos and No in Human Melanoma: Possible Role in Regulation of Growth and Resistance to Apoptosis. Nitric Oxide 2008, 19:133-137.
98. Grohmann U., Bianchi R., Belladonna M.L., Silla S., Fallarino F., Fioretti M.C., et al. Ifn-Gamma Inhibits Presentation of a Tumor/Self Peptide by CD8 Alpha- Dendritic Cells Via Potentiation of the CD8 Alpha+ Subset. J Immunol 2000, 165:1357-1363.
99. Grohmann U., Bronte V. Control of Immune Response by Amino Acid Metabolism. Immunol Rev 2010, 236:243-264.
100. Grohmann U., Fallarino F., Bianchi R., Orabona C., Vacca C., Fioretti M.C., et al. Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice. J Exp Med 2003, 198:153-160.
101. Grohmann U., Fallarino F., Bianchi R., Vacca C., Orabona C., Belladonna M.L., et al. Tryptophan Catabolism in Nonobese Diabetic Mice. Adv Exp Med Biol 2003, 527:47-54.
102. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., et al. CTLA-4-Ig Regulates Tryptophan Catabolism in Vivo. Nat Immunol 2002, 3:1097-1101.
103. Guzik T.J., Korbut R., Adamek-Guzik T. Nitric Oxide and Superoxide in Inflammation and Immune Regulation. J Physiol Pharmacol 2003, 54:469-487.
104. Haffner I., Teupser D., Holdt L.M., Ernst J., Burkhardt R., Thiery J. Regulation of Arginase-1 Expression in Macrophages by a Protein Kinase a Type I and Histone Deacetylase Dependent Pathway. J Cell Biochem 2008, 103:520-527.
105. Hajri A., Metzger E., Vallat F., Coffy S., Flatter E., Evrard S., et al. Role of Nitric Oxide in Pancreatic Tumour Growth: In Vivo and in Vitro Studies. Br J Cancer 1998, 78:841-849.
106. + CD56(Dim) Subset. J Immunol 2007, 179:4513-4519.
107. Hausel P., Latado H., Courjault-Gautier F., Felley-Bosco E. Src-Mediated Phosphorylation Regulates Subcellular Distribution and Activity of Human Inducible Nitric Oxide Synthase. Oncogene 2006, 25:198-206.
108. Haverkamp J.M., Crist S.A., Elzey B.D., Cimen C., Ratliff T.L. Vivo Suppressive Function of Myeloid-Derived Suppressor Cells Is Limited to the Inflammatory Site. Eur J Immunol 2011, 41:749-759.
109. Hecker M., Nematollahi H., Hey C., Busse R., Racke K. Inhibition of Arginase by Ng-Hydroxy-L-Arginine in Alveolar Macrophages: Implications for the Utilization of L-Arginine for Nitric Oxide Synthesis. FEBS Lett 1995, 359:251-254.
110. Highfill S.L., Rodriguez P.C., Zhou Q., Goetz C.A., Koehn B.H., Veenstra R., et al. Bone Marrow Myeloid-Derived Suppressor Cells (MDSCs) Inhibit Graft-Versus-Host Disease (GVHD) Via an Arginase-1-Dependent Mechanism That Is up-Regulated by Interleukin-13. Blood 2010, 116:5738-5747.
111. Hildeman D.A., Mitchell T., Aronow B., Wojciechowski S., Kappler J., Marrack P. Control of Bcl-2 Expression by Reactive Oxygen Species. Proc Natl Acad Sci U S A 2003, 100:15035-15040.
112. Hildeman D.A., Mitchell T., Kappler J., Marrack P.T. Cell Apoptosis and Reactive Oxygen Species. J Clin Invest 2003, 111:575-581.
113. Hildeman D.A., Mitchell T., Teague T.K., Henson P., Day B.J., Kappler J., et al. Reactive Oxygen Species Regulate Activation-Induced T Cell Apoptosis. Immunity 1999, 10:735-744.
114. Hinz B., Brune K., Pahl A. Nitric Oxide Inhibits Inducible Nitric Oxide Synthase mRNA Expression in RAW 264.7 Macrophages. Biochem Biophys Res Commun 2000, 271:353-357.
115. Hiraku Y., Kawanishi S., Ichinose T., Murata M. The Role of iNOS-Mediated DNA Damage in Infection- and Asbestos-Induced Carcinogenesis. Ann N Y Acad Sci 2010, 1203:15-22.
116. Hrabak A., Bajor T., Csuka I. The Effect of Various Inflammatory Agents on the Alternative Metabolic Pathways of Arginine in Mouse and Rat Macrophages. Inflamm Res 2006, 55:23-31.
117. Hucke C., MacKenzie C.R., Adjogble K.D., Takikawa O., Daubener W. Nitric Oxide-Mediated Regulation of Gamma Interferon-Induced Bacteriostasis: Inhibition and Degradation of Human Indoleamine 2,3-Dioxygenase. Infect Immun 2004, 72:2723-2730.
118. Hussain S.P., Hofseth L.J., Harris C.C. Radical Causes of Cancer. Nat Rev Cancer 2003, 3:276-285.
119. Hussain S.P., Trivers G.E., Hofseth L.J., He P., Shaikh I., Mechanic L.E., et al. Nitric Oxide, a Mediator of Inflammation, Suppresses Tumorigenesis. Cancer Res 2004, 64:6849-6853.
120. Ibiza S., Victor V.M., Bosca I., Ortega A., Urzainqui A., O'Connor J.E., et al. Endothelial Nitric Oxide Synthase Regulates T Cell Receptor Signaling at the Immunological Synapse. Immunity 2006, 24:753-765.
121. Ichinoe M., Mikami T., Shiraishi H., Okayasu I. High Microvascular Density Is Correlated with High VEGF, iNOS and COX-2 Expression in Penetrating Growth-Type Early Gastric Carcinomas. Histopathology 2004, 45:612-618.
122. Iniesta V., Gomez-Nieto L.C., Corraliza I. The Inhibition of Arginase by N(Omega)-Hydroxy-L-Arginine Controls the Growth of Leishmania inside Macrophages. J Exp Med 2001, 193:777-784.
123. Ishii Y., Ogura T., Tatemichi M., Fujisawa H., Otsuka F., Esumi H. Induction of Matrix Metalloproteinase Gene Transcription by Nitric Oxide and Mechanisms of MMP-1 Gene Induction in Human Melanoma Cell Lines. Int J Cancer 2003, 103:161-168.
124. Iyer R.K., Yoo P.K., Kern R.M., Rozengurt N., Tsoa R., O'Brien W.E., et al. Mouse Model for Human Arginase Deficiency. Mol Cell Biol 2002, 22:4491-4498.
125. Jadeski L.C., Chakraborty C., Lala P.K. Nitric Oxide-Mediated Promotion of Mammary Tumour Cell Migration Requires Sequential Activation of Nitric Oxide Synthase, Guanylate Cyclase and Mitogen-Activated Protein Kinase. Int J Cancer 2003, 106:496-504.
126. Jaiswal M., LaRusso N.F., Burgart L.J., Gores G.J. Inflammatory Cytokines Induce DNA Damage and Inhibit DNA Repair in Cholangiocarcinoma Cells by a Nitric Oxide-Dependent Mechanism. Cancer Res 2000, 60:184-190.
127. Jayasekera J.P., Vinuesa C.G., Karupiah G., King N.J. Enhanced Antiviral Antibody Secretion and Attenuated Immunopathology During Influenza Virus Infection in Nitric Oxide Synthase-2-Deficient Mice. J Gen Virol 2006, 87:3361-3371.
128. Jost M.M., Ninci E., Meder B., Kempf C., Van Royen N., Hua J., et al. Divergent Effects of GM-CSF and TGFbeta1 on Bone Marrow-Derived Macrophage Arginase-1 Activity, MCP-1 Expression, and Matrix Metalloproteinase-12: A Potential Role During Arteriogenesis. FASEB J 2003, 17:2281-2283.
129. Kai H., Ito M., Kitadai Y., Tanaka S., Haruma K., Chayama K. Chronic Gastritis with Expression of Inducible Nitric Oxide Synthase Is Associated with High Expression of Interleukin-6 and Hypergastrinaemia. Aliment Pharmacol Ther 2004, 19:1309-1314.
130. Karin M., Greten F.R. NF-KappaB: Linking Inflammation and Immunity to Cancer Development and Progression. Nat Rev Immunol 2005, 5:749-759.
131. Kasic T., Colombo P., Soldani C., Wang C.M., Miranda E., Roncalli M., et al. Modulation of Human T-Cell Functions by Reactive Nitrogen Species. Eur J Immunol 2011, 41:1843-1849.
132. Kasuno K., Takabuchi S., Fukuda K., Kizaka-Kondoh S., Yodoi J., Adachi T., et al. Nitric Oxide Induces Hypoxia-Inducible Factor 1 Activation That Is Dependent on MAPK and Phosphatidylinositol 3-Kinase Signaling. J Biol Chem 2004, 279:2550-2558.
133. Kato H., Miyazaki T., Yoshikawa M., Nakajima M., Fukai Y., Tajima K., et al. Nitrotyrosine in Esophageal Squamous Cell Carcinoma and Relevance to p53 Expression. Cancer Lett 2000, 153:121-127.
134. Keskinege A., Elgun S., Yilmaz E. Possible Implications of Arginase and Diamine Oxidase in Prostatic Carcinoma. Cancer Detect Prev 2001, 25:76-79.
135. Kim S.F., Huri D.A., Snyder S.H. Inducible Nitric Oxide Synthase Binds, S-Nitrosylates, and Activates Cyclooxygenase-2. Science 2005, 310:1966-1970.
136. Kimura H., Weisz A., Kurashima Y., Hashimoto K., Ogura T., D'Acquisto F., et al. Hypoxia Response Element of the Human Vascular Endothelial Growth Factor Gene Mediates Transcriptional Regulation by Nitric Oxide: Control of Hypoxia-Inducible Factor-1 Activity by Nitric Oxide. Blood 2000, 95:189-197.
137. Kinnula V.L., Torkkeli T., Kristo P., Sormunen R., Soini Y., Paakko P., et al. Ultrastructural and Chromosomal Studies on Manganese Superoxide Dismutase in Malignant Mesothelioma. Am J Respir Cell Mol Biol 2004, 31:147-153.
138. Kisley L.R., Barrett B.S., Bauer A.K., Dwyer-Nield L.D., Barthel B., Meyer A.M., et al. Genetic Ablation of Inducible Nitric Oxide Synthase Decreases Mouse Lung Tumorigenesis. Cancer Res 2002, 62:6850-6856.
139. Kleinert H., Schwarz P.M., Forstermann U. Regulation of the Expression of Inducible Nitric Oxide Synthase. Biol Chem 2003, 384:1343-1364.
140. Klotz T., Bloch W., Volberg C., Engelmann U., Addicks K. Selective Expression of Inducible Nitric Oxide Synthase in Human Prostate Carcinoma. Cancer 1998, 82:1897-1903.
141. Knowles R.G., Moncada S. Nitric Oxide Synthases in Mammals. Biochem J 1994, 298(Pt 2):249-258.
142. Koblish H.K., Hunter C.A., Wysocka M., Trinchieri G., Lee W.M. Immune Suppression by Recombinant Interleukin (rIL)-12 Involves Interferon Gamma Induction of Nitric Oxide Synthase 2 (iNOS) Activity: Inhibitors of NO Generation Reveal the Extent of rIL-12 Vaccine Adjuvant Effect. J Exp Med 1998, 188:1603-1610.
143. Koh K.P., Wang Y., Yi T., Shiao S.L., Lorber M.I., Sessa W.C., et al. T Cell-Mediated Vascular Dysfunction of Human Allografts Results from Ifn-Gamma Dysregulation of NO Synthase. J Clin Invest 2004, 114:846-856.
144. Kolb H., Kolb-Bachofen V. Nitric Oxide in Autoimmune Disease: Cytotoxic or Regulatory Mediator?. Immunol Today 1998, 19:556-561.
145. Kong S.K., Yim M.B., Stadtman E.R., Chock P.B. Peroxynitrite Disables the Tyrosine Phosphorylation Regulatory Mechanism: Lymphocyte-Specific Tyrosine Kinase Fails to Phosphorylate Nitrated Cdc2(6-20)Nh2 Peptide. Proc Natl Acad Sci U S A 1996, 93:3377-3382.
146. Kropf P., Baud D., Marshall S.E., Munder M., Mosley A., Fuentes J.M., et al. Arginase Activity Mediates Reversible T Cell Hyporesponsiveness in Human Pregnancy. Eur J Immunol 2007, 37:935-945.
147. Kung J.T., Brooks S.B., Jakway J.P., Leonard L.L., Talmage D.W. Suppression of in Vitro Cytotoxic Response by Macrophages Due to Induced Arginase. J Exp Med 1977, 146:665-672.
148. Kuraishy A., Karin M., Grivennikov S.I. Tumor Promotion Via Injury- and Death-Induced Inflammation. Immunity 2011, 35:467-477.
149. Kusmartsev S., Gabrilovich D.I. STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion. J Immunol 2005, 174:4880-4891.
150. + Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced through CD3/CD28 Costimulation. J Immunol 2000, 165:779-785.
151. + T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species. J Immunol 2004, 172:989-999.
152. Lala P.K., Chakraborty C. Role of Nitric Oxide in Carcinogenesis and Tumour Progression. Lancet Oncol 2001, 2:149-156.
153. + T Cells During Primary but Not Secondary Viral Infection. J Virol 2004, 78:11246-11257.
154. Laroux F.S., Pavlick K.P., Hines I.N., Kawachi S., Harada H., Bharwani S., et al. Role of Nitric Oxide in Inflammation. Acta Physiol Scand 2001, 173:113-118.
155. Lee J., Ryu H., Ferrante R.J., Morris S.M., Ratan R.R. Translational Control of Inducible Nitric Oxide Synthase Expression by Arginine Can Explain the Arginine Paradox. Proc Natl Acad Sci U S A 2003, 100:4843-4848.
156. Leon L., Jeannin J.F., Bettaieb A. Post-Translational Modifications Induced by Nitric Oxide (NO): Implication in Cancer Cells Apoptosis. Nitric Oxide 2008, 19:77-83.
157. Lewis N.D., Asim M., Barry D.P., Singh K., de Sablet T., Boucher J.L., et al. Arginase II Restricts Host Defense to Helicobacter Pylori by Attenuating Inducible Nitric Oxide Synthase Translation in Macrophages. J Immunol 2010, 184:2572-2582.
158. Li W., Lidebjer C., Yuan X.M., Szymanowski A., Backteman K., Ernerudh J., et al. Cell Apoptosis in Coronary Artery Disease: Relation to Oxidative Stress. Atherosclerosis 2008, 199:65-72.
159. Loibl S., Buck A., Strank C., von Minckwitz G., Roller M., Sinn H.P., et al. The Role of Early Expression of Inducible Nitric Oxide Synthase in Human Breast Cancer. Eur J Cancer 2005, 41:265-271.
160. Loibl S., von Minckwitz G., Weber S., Sinn H.P., Schini-Kerth V.B., Lobysheva I., et al. Expression of Endothelial and Inducible Nitric Oxide Synthase in Benign and Malignant Lesions of the Breast and Measurement of Nitric Oxide Using Electron Paramagnetic Resonance Spectroscopy. Cancer 2002, 95:1191-1198.
161. Lopez-Rivera E., Lizarbe T.R., Martinez-Moreno M., Lopez-Novoa J.M., Rodriguez-Barbero A., Rodrigo J., et al. Matrix Metalloproteinase 13 Mediates Nitric Oxide Activation of Endothelial Cell Migration. Proc Natl Acad Sci U S A 2005, 102:3685-3690.
162. Lundberg J.O., Lundberg J.M., Alving K., Weitzberg E. Nitric Oxide and Inflammation: The Answer Is Blowing in the Wind. Nat Med 1997, 3:30-31.
163. Ma N., Adachi Y., Hiraku Y., Horiki N., Horiike S., Imoto I., et al. Accumulation of 8-Nitroguanine in Human Gastric Epithelium Induced by Helicobacter Pylori Infection. Biochem Biophys Res Commun 2004, 319:506-510.
164. Macarthur M., Hold G.L., El-Omar E.M. Inflammation and Cancer Ii. Role of Chronic Inflammation and Cytokine Gene Polymorphisms in the Pathogenesis of Gastrointestinal Malignancy. Am J Physiol Gastrointest Liver Physiol 2004, 286:G515-G520.
165. MacMicking J., Xie Q.W., Nathan C. Nitric Oxide and Macrophage Function. Annu Rev Immunol 1997, 15:323-350.
166. Macphail S.E., Gibney C.A., Brooks B.M., Booth C.G., Flanagan B.F., Coleman J.W. Nitric Oxide Regulation of Human Peripheral Blood Mononuclear Cells: Critical Time Dependence and Selectivity for Cytokine Versus Chemokine Expression. J Immunol 2003, 171:4809-4815.
167. Malmberg K., Arulampalam V., Ichihara F., Petersson M., Seki K., Andersson T., et al. Inhibition of Activated/Memory (CD45RO(+)) T Cells by Oxidative Stress Associated with Block of NF-KB Activation. J Immunol 2001, 167:2595-2601.
168. Mandruzzato S., Callegaro A., Turcatel G., Francescato S., Montesco M.C., Chiarion-Sileni V., et al. Gene Expression Signature Associated with Survival in Metastatic Melanoma. J Transl Med 2006, 4:50.
169. + Myeloid-Derived Suppressor Cell Expansion in Cancer Patients. J Immunol 2009, 182:6562-6568.
170. Mann G.E., Yudilevich D.L., Sobrevia L. Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells. Physiol Rev 2003, 83:183-252.
171. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., et al. Fas-Induced Caspase Denitrosylation. Science 1999, 284:651-654.
172. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage Polarization: Tumor-Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes. Trends Immunol 2002, 23:549-555.
173. Margalit O., Eisenbach L., Amariglio N., Kaminski N., Harmelin A., Pfeffer R., et al. Overexpression of a Set of Genes, Including WISP-1, Common to Pulmonary Metastases of Both Mouse D122 Lewis Lung Carcinoma and B16-F10.9 Melanoma Cell Lines. Br J Cancer 2003, 89:314-319.
174. Mariotto S., Cuzzolin L., Adami A., Del Soldato P., Suzuki H., Benoni G. Effect of a New Non-Steroidal Anti-Inflammatory Drug, Nitroflurbiprofen, on the Expression of Inducible Nitric Oxide Synthase in Rat Neutrophils. Br J Pharmacol 1995, 115:225-226.
175. Marnett L.J., Riggins J.N., West J.D. Endogenous Generation of Reactive Oxidants and Electrophiles and Their Reactions with DNA and Protein. J Clin Invest 2003, 111:583-593.
176. Marrogi A., Pass H.I., Khan M., Metheny-Barlow L.J., Harris C.C., Gerwin B.I. Human Mesothelioma Samples Overexpress Both Cyclooxygenase-2 (COX-2) and Inducible Nitric Oxide Synthase (NOS2): In Vitro Antiproliferative Effects of a COX-2 Inhibitor. Cancer Res 2000, 60:3696-3700.
177. Massi D., Franchi A., Sardi I., Magnelli L., Paglierani M., Borgognoni L., et al. Inducible Nitric Oxide Synthase Expression in Benign and Malignant Cutaneous Melanocytic Lesions. J Pathol 2001, 194:194-200.
178. Massi D., Marconi C., Franchi A., Bianchini F., Paglierani M., Ketabchi S., et al. Arginine Metabolism in Tumor-Associated Macrophages in Cutaneous Malignant Melanoma: Evidence from Human and Experimental Tumors. Hum Pathol 2007, 38:1516-1525.
179. Matsuda M., Petersson M., Lenkei R., Taupin J.L., Magnusson I., Mellstedt H., et al. Alterations in the Signal-Transducing Molecules of T Cells and NK Cells in Colorectal Tumor-Infiltrating, Gut Mucosal and Peripheral Lymphocytes: Correlation with the Stage of the Disease. Int J Cancer 1995, 61:765-772.
180. Matsui K., Nishizawa M., Ozaki T., Kimura T., Hashimoto I., Yamada M., et al. Natural Antisense Transcript Stabilizes Inducible Nitric Oxide Synthase Messenger Rna in Rat Hepatocytes. Hepatology 2008, 47:686-697.
181. Matthiesen S., Lindemann D., Warnken M., Juergens U.R., Racke K. Inhibition of NADPH Oxidase by Apocynin Inhibits Lipopolysaccharide (LPS) Induced up-Regulation of Arginase in Rat Alveolar Macrophages. Eur J Pharmacol 2008, 579:403-410.
182. Mazzoni A., Bronte V., Visintin A., Spitzer J.H., Apolloni E., Serafini P., et al. Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism. J Immunol 2002, 168:689-695.
183. McKnight R., Nassar A., Cohen C., Siddiqui M.T. Arginase-1: A Novel Immunohistochemical Marker of Hepatocellular Differentiation in Fine Needle Aspiration Cytology. Cancer Cytopathol 2012.
184. Medeiros R., Morais A., Vasconcelos A., Costa S., Pinto D., Oliveira J., et al. Endothelial Nitric Oxide Synthase Gene Polymorphisms and Genetic Susceptibility to Prostate Cancer. Eur J Cancer Prev 2002, 11:343-350.
185. Melillo G., Musso T., Sica A., Taylor L.S., Cox G.W., Varesio L.A. Hypoxia-Responsive Element Mediates a Novel Pathway of Activation of the Inducible Nitric Oxide Synthase Promoter. J Exp Med 1995, 182:1683-1693.
186. + Myeloid Cells Inhibit Development of Antifungal Th1 Immunity in Mice with Candidiasis. J Immunol 2002, 169:3180-3190.
187. Mendes R.V., Martins A.R., de Nucci G., Murad F., Soares F.A. Expression of Nitric Oxide Synthase Isoforms and Nitrotyrosine Immunoreactivity by B-Cell Non-Hodgkin's Lymphomas and Multiple Myeloma. Histopathology 2001, 39:172-178.
188. Meurs H., Maarsingh H., Zaagsma J. Arginase and Asthma: Novel Insights into Nitric Oxide Homeostasis and Airway Hyperresponsiveness. Trends Pharmacol Sci 2003, 24:450-455.
189. Michel T., Feron O. Nitric Oxide Synthases: Which, Where, How, and Why?. J Clin Invest 1997, 100:2146-2152.
190. Mielczarek M., Chrzanowska A., Scibior D., Skwarek A., Ashamiss F., Lewandowska K., et al. Arginase as a Useful Factor for the Diagnosis of Colorectal Cancer Liver Metastases. Int J Biol Markers 2006, 21:40-44.
191. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 Macrophages and the Th1/Th2 Paradigm. J Immunol 2000, 164:6166-6173.
192. Mocellin S., Bronte V., Nitti D. Nitric Oxide, a Double Edged Sword in Cancer Biology: Searching for Therapeutic Opportunities. Med Res Rev 2007, 27:317-352.
193. Mocellin S., Mandruzzato S., Bronte V., Lise M., Nitti D. Vaccines for Solid Tumours. Part I: Lancet Oncol 2004, 5:681-689.
194. Mocellin S., Provenzano M., Rossi C.R., Pilati P., Scalerta R., Lise M., et al. Induction of Endothelial Nitric Oxide Synthase Expression by Melanoma Sensitizes Endothelial Cells to Tumor Necrosis Factor-Driven Cytotoxicity. Clin Cancer Res 2004, 10:6879-6886.
195. Mocellin S., Semenzato G., Mandruzzato S., Riccardo Rossi C. Vaccines for Haematological Malignant Disorders. Part II: Lancet Oncol 2004, 5:727-737.
196. Mollace V., Muscoli C., Masini E., Cuzzocrea S., Salvemini D. Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors. Pharmacol Rev 2005, 57:217-252.
197. Molon B., Ugel S., Del Pozzo F., Soldani C., Zilio S., Avella D., et al. Chemokine Nitration Prevents Intratumoral Infiltration of Antigen-Specific T Cells. J Exp Med 2011, 208:1949-1962.
198. Moncada S., Palmer R.M., Higgs E.A. Nitric Oxide: Physiology, Pathophysiology, and Pharmacology. Pharmacol Rev 1991, 43:109-142.
199. Morbidelli L., Donnini S., Ziche M. Role of Nitric Oxide in Tumor Angiogenesis. Cancer Treat Res 2004, 117:155-167.
200. Mori N., Nunokawa Y., Yamada Y., Ikeda S., Tomonaga M., Yamamoto N. Expression of Human Inducible Nitric Oxide Synthase Gene in T-Cell Lines Infected with Human T-Cell Leukemia Virus Type-I and Primary Adult T-Cell Leukemia Cells. Blood 1999, 94:2862-2870.
201. Morin J., Chimenes A., Boitard C., Berthier R., Boudaly S. Granulocyte-Dendritic Cell Unbalance in the Non-Obese Diabetic Mice. Cell Immunol 2003, 223:13-25.
202. Morris S.M. Regulation of Enzymes of the Urea Cycle and Arginine Metabolism. Annu Rev Nutr 2002, 22:87-105.
203. Morrison A.C., Correll P.H. Activation of the Stem Cell-Derived Tyrosine Kinase/Ron Receptor Tyrosine Kinase by Macrophage-Stimulating Protein Results in the Induction of Arginase Activity in Murine Peritoneal Macrophages. J Immunol 2002, 168:853-860.
204. Mougiakakos D., Johansson C.C., Jitschin R., Bottcher M., Kiessling R. Increased Thioredoxin-1 Production in Human Naturally Occurring Regulatory T Cells Confers Enhanced Tolerance to Oxidative Stress. Blood 2011, 117:857-861.
205. Mougiakakos D., Johansson C.C., Kiessling R. Naturally Occurring Regulatory T Cells Show Reduced Sensitivity Towards Oxidative Stress Induced Cell Death. Blood 2008.
206. Moulian N., Truffault F., Gaudry-Talarmain Y.M., Serraf A., Berrih-Aknin S. Vivo and in Vitro Apoptosis of Human Thymocytes Are Associated with Nitrotyrosine Formation. Blood 2001, 97:3521-3530.
207. Munder M. Arginase: An Emerging Key Player in the Mammalian Immune System. Br J Pharmacol 2009, 158:638-651.
208. + T Cells Correlates with Th1/Th2 Phenotype. J Immunol 1998, 160:5347-5354.
209. Munder M., Eichmann K., Moran J.M., Centeno F., Soler G., Modolell M. Th1/Th2-Regulated Expression of Arginase Isoforms in Murine Macrophages and Dendritic Cells. J Immunol 1999, 163:3771-3777.
210. Munder M., Mollinedo F., Calafat J., Canchado J., Gil-Lamaignere C., Fuentes J.M., et al. Arginase I Is Constitutively Expressed in Human Granulocytes and Participates in Fungicidal Activity. Blood 2005, 105:2549-2556.
211. Munder M., Schneider H., Luckner C., Giese T., Langhans C.D., Fuentes J., et al. Suppression of T Cell Functions by Human Granulocyte Arginase. Blood 2006.
212. Munn D.H., Sharma M.D., Baban B., Harding H.P., Zhang Y., Ron D., et al. GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase. Immunity 2005, 22:633-642.
213. + Cell Responses. J Immunol 2003, 170:2727-2733.
214. Nagaraj S., Youn J.I., Weber H., Iclozan C., Lu L., Cotter M.J., et al. Anti-Inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer. Clin Cancer Res 2010, 16:1812-1823.
215. Nakamura Y., Yasuoka H., Tsujimoto M., Yoshidome K., Nakahara M., Nakao K., et al. Nitric Oxide in Breast Cancer: Induction of Vascular Endothelial Growth Factor-C and Correlation with Metastasis and Poor Prognosis. Clin Cancer Res 2006, 12:1201-1207.
216. Nelson W.G., De Marzo A.M., DeWeese T.L., Isaacs W.B. The Role of Inflammation in the Pathogenesis of Prostate Cancer. J Urol 2004, 172:S6-11. Discussion S-2.
217. +CD25 T Cells Via p53, IL-2, and OX40. Proc Natl Acad Sci U S A 2007, 104:15478-15483.
218. Niedbala W., Wei X.Q., Piedrafita D., Xu D., Liew F.Y. Effects of Nitric Oxide on the Induction and Differentiation of Th1 Cells. Eur J Immunol 1999, 29:2498-2505.
219. Norman M.U., Zbytnuik L., Kubes P. Interferon-Gamma Limits Th1 Lymphocyte Adhesion to Inflamed Endothelium: A Nitric Oxide Regulatory Feedback Mechanism. Eur J Immunol 2008, 38:1368-1380.
220. Nosho K., Yamamoto H., Adachi Y., Endo T., Hinoda Y., Imai K. Gene Expression Profiling of Colorectal Adenomas and Early Invasive Carcinomas by cDNA Array Analysis. Br J Cancer 2005, 92:1193-1200.
221. Nozoe T., Yasuda M., Honda M., Inutsuka S., Korenaga D. Immunohistochemical Expression of Cytokine Induced Nitric Oxide Synthase in Colorectal Carcinoma. Oncol Rep 2002, 9:521-524.
222. Ohshima H., Tatemichi M., Sawa T. Chemical Basis of Inflammation-Induced Carcinogenesis. Arch Biochem Biophys 2003, 417:3-11.
223. Okamoto T., Akaike T., Sawa T., Miyamoto Y., van der Vliet A., Maeda H. Activation of Matrix Metalloproteinases by Peroxynitrite-Induced Protein S-Glutathiolation Via Disulfide S-Oxide Formation. J Biol Chem 2001, 276:29596-29602.
224. Ostrand-Rosenberg S., Sinha P., Beury D.W., Clements V.K. Cross-Talk between Myeloid-Derived Suppressor Cells (MDSC), Macrophages, and Dendritic Cells Enhances Tumor-Induced Immune Suppression. Semin Cancer Biol 2012.
225. Otsuji M., Kimura Y., Aoe T., Okamoto Y., Saito T. Oxidative Stress by Tumor-Derived Macrophages Suppresses the Expression of CD3 Zeta Chain of T-Cell Receptor Complex and Antigen-Specific T- Cell Responses. Proc Natl Acad Sci U S A 1996, 93:13119-13124.
226. Ouyang N., Williams J.L., Tsioulias G.J., Gao J., Iatropoulos M.J., Kopelovich L., et al. Nitric Oxide-Donating Aspirin Prevents Pancreatic Cancer in a Hamster Tumor Model. Cancer Res 2006, 66:4503-4511.
227. Park I.S., Kang S.W., Shin Y.J., Chae K.Y., Park M.O., Kim M.Y., et al. Arginine Deiminase: A Potential Inhibitor of Angiogenesis and Tumour Growth. Br J Cancer 2003, 89:907-914.
228. Park S.W., Lee S.G., Song S.H., Heo D.S., Park B.J., Lee D.W., et al. The Effect of Nitric Oxide on Cyclooxygenase-2 (COX-2) Overexpression in Head and Neck Cancer Cell Lines. Int J Cancer 2003, 107:729-738.
229. Pauleau A.L., Rutschman R., Lang R., Pernis A., Watowich S.S., Murray P.J. Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression. J Immunol 2004, 172:7565-7573.
230. Pautz A., Art J., Hahn S., Nowag S., Voss C., Kleinert H. Regulation of the Expression of Inducible Nitric Oxide Synthase. Nitric Oxide 2010, 23:75-93.
231. Peranzoni E., Marigo I., Dolcetti L., Ugel S., Sonda N., Taschin E., et al. Role of Arginine Metabolism in Immunity and Immunopathology. Immunobiology 2007, 212:795-812.
232. Perez G.M., Melo M., Keegan A.D., Zamorano J. Aspirin and Salicylates Inhibit the IL-4- and IL-13-Induced Activation of STAT6. J Immunol 2002, 168:1428-1434.
233. Perrella M.A., Pellacani A., Wiesel P., Chin M.T., Foster L.C., Ibanez M., et al. High Mobility Group-I(Y) Protein Facilitates Nuclear Factor-Kappab Binding and Transactivation of the Inducible Nitric-Oxide Synthase Promoter/Enhancer. J Biol Chem 1999, 274:9045-9052.
234. Pignatelli B., Li C.Q., Boffetta P., Chen Q., Ahrens W., Nyberg F., et al. Nitrated and Oxidized Plasma Proteins in Smokers and Lung Cancer Patients. Cancer Res 2001, 61:778-784.
235. Polat M.F., Taysi S., Polat S., Boyuk A., Bakan E. Elevated Serum Arginase Activity Levels in Patients with Breast Cancer. Surg Today 2003, 33:655-661.
236. Porembska Z., Luboinski G., Chrzanowska A., Mielczarek M., Magnuska J., Baranczyk-Kuzma A. Arginase in Patients with Breast Cancer. Clin Chim Acta 2003, 328:105-111.
237. Porembska Z., Skwarek A., Mielczarek M., Baranczyk-Kuzma A. Serum Arginase Activity in Postsurgical Monitoring of Patients with Colorectal Carcinoma. Cancer 2002, 94:2930-2934.
238. Poschke I., Mougiakakos D., Kiessling R. Camouflage and Sabotage: Tumor Escape from the Immune System. Cancer Immunol Immunother 2011, 60:1161-1171.
239. Priceman S.J., Sung J.L., Shaposhnik Z., Burton J.B., Torres-Collado A.X., Moughon D.L., et al. Targeting Distinct Tumor-Infiltrating Myeloid Cells by Inhibiting CSF-1 Receptor: Combating Tumor Evasion of Antiangiogenic Therapy. Blood 2010, 115:1461-1471.
240. Qian B.Z., Pollard J.W. Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell 2010, 141:39-51.
241. Qiu H., Orr F.W., Jensen D., Wang H.H., McIntosh A.R., Hasinoff B.B., et al. Arrest of B16 Melanoma Cells in the Mouse Pulmonary Microcirculation Induces Endothelial Nitric Oxide Synthase-Dependent Nitric Oxide Release That Is Cytotoxic to the Tumor Cells. Am J Pathol 2003, 162:403-412.
242. Radi R. Nitric Oxide, Oxidants, and Protein Tyrosine Nitration. Proc Natl Acad Sci U S A 2004, 101:4003-4008.
243. Raes G., Van den Bergh R., De Baetselier P., Ghassabeh G.H., Scotton C., Locati M., et al. Arginase-1 and YM1 Are Markers for Murine, but Not Human, Alternatively Activated Myeloid Cells. J Immunol 2005, 174:6561.
244. Rao C.V. Nitric Oxide Signaling in Colon Cancer Chemoprevention. Mutat Res 2004, 555:107-119.
245. Rao C.V., Reddy B.S., Steele V.E., Wang C.X., Liu X., Ouyang N., et al. Nitric Oxide-Releasing Aspirin and Indomethacin Are Potent Inhibitors against Colon Cancer in Azoxymethane-Treated Rats: Effects on Molecular Targets. Mol Cancer Ther 2006, 5:1530-1538.
246. Raspollini M.R., Amunni G., Villanucci A., Boddi V., Baroni G., Taddei A., et al. Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Ovarian Cancer: Correlation with Clinical Outcome. Gynecol Oncol 2004, 92:806-812.
247. Ratovitski E.A., Bao C., Quick R.A., McMillan A., Kozlovsky C., Lowenstein C.J. An Inducible Nitric-Oxide Synthase (NOS)-Associated Protein Inhibits Nos Dimerization and Activity. J Biol Chem 1999, 274:30250-30257.
248. Reth M. Hydrogen Peroxide as Second Messenger in Lymphocyte Activation. Nat Immunol 2002, 3:1129-1134.
249. Reveneau S., Arnould L., Jolimoy G., Hilpert S., Lejeune P., Saint-Giorgio V., et al. Nitric Oxide Synthase in Human Breast Cancer Is Associated with Tumor Grade, Proliferation Rate, and Expression of Progesterone Receptors. Lab Invest 1999, 79:1215-1225.
250. Rodriguez-Pascual F., Hausding M., Ihrig-Biedert I., Furneaux H., Levy A.P., Forstermann U., et al. Complex Contribution of the 3'-Untranslated Region to the Expressional Regulation of the Human Inducible Nitric-Oxide Synthase Gene. Involvement of the RNA-Binding Protein HuR. J Biol Chem 2000, 275:26040-26049.
251. Rodriguez P.C., Ernstoff M.S., Hernandez C., Atkins M., Zabaleta J., Sierra R., et al. Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes. Cancer Res 2009, 69:1553-1560.
252. Rodriguez P.C., Hernandez C.P., Quiceno D., Dubinett S.M., Zabaleta J., Ochoa J.B., et al. Arginase I in Myeloid Suppressor Cells Is Induced by COX-2 in Lung Carcinoma. J Exp Med 2005, 202:931-939.
253. Rodriguez P.C., Ochoa A.C. T Cell Dysfunction in Cancer: Role of Myeloid Cells and Tumor Cells Regulating Amino Acid Availability and Oxidative Stress. Semin Cancer Biol 2006, 16:66-72.
254. Rodriguez P.C., Quiceno D.G., Zabaleta J., Ortiz B., Zea A.H., Piazuelo M.B., et al. Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses. Cancer Res 2004, 64:5839-5849.
255. Rodriguez P.C., Zea A.H., Culotta K.S., Zabaleta J., Ochoa J.B., Ochoa A.C. Regulation of T Cell Receptor Cd3zeta Chain Expression by L-Arginine. J Biol Chem 2002, 277:21123-21129.
256. Rodriguez P.C., Zea A.H., DeSalvo J., Culotta K.S., Zabaleta J., Quiceno D.G., et al. L-Arginine Consumption by Macrophages Modulates the Expression of CD3 Zeta Chain in T Lymphocytes. J Immunol 2003, 171:1232-1239.
257. Roman V., Zhao H., Fourneau J.M., Marconi A., Dugas N., Dugas B., et al. Expression of a Functional Inducible Nitric Oxide Synthase in Hairy Cell Leukaemia and ESKOL Cell Line. Leukemia 2000, 14:696-705.
258. Rosenberg S.A., Yang J.C., Restifo N.P. Cancer Immunotherapy: Moving Beyond Current Vaccines. Nat Med 2004, 10:909-915.
259. Rothe H., Hausmann A., Kolb H. Immunoregulation During Disease Progression in Prediabetic Nod Mice: Inverse Expression of Arginase and Prostaglandin H Synthase 2 Vs. Interleukin-15. Horm Metab Res 2002, 34:7-12.
260. Rotondo R., Barisione G., Mastracci L., Grossi F., Orengo A.M., Costa R., et al. IL-8 Induces Exocytosis of Arginase 1 by Neutrophil Polymorphonuclears in Nonsmall Cell Lung Cancer. Int J Cancer 2009, 125:887-893.
261. Rotondo R., Bertolotto M., Barisione G., Astigiano S., Mandruzzato S., Ottonello L., et al. Exocytosis of Azurophil and Arginase 1-Containing Granules by Activated Polymorphonuclear Neutrophils Is Required to Inhibit T Lymphocyte Proliferation. J Leukoc Biol 2011, 89:721-727.
262. Routledge M.N. Mutations Induced by Reactive Nitrogen Oxide Species in the Supf Forward Mutation Assay. Mutat Res 2000, 450:95-105.
263. Sandler R.S., Halabi S., Baron J.A., Budinger S., Paskett E., Keresztes R., et al. Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer. N Engl J Med 2003, 348:883-890.
264. Schluns K.S., Lefrancois L. Cytokine Control of Memory T-Cell Development and Survival. Nat Rev Immunol 2003, 3:269-279.
265. Schmidt N., Pautz A., Art J., Rauschkolb P., Jung M., Erkel G., et al. Transcriptional and Post-Transcriptional Regulation of iNOS Expression in Human Chondrocytes. Biochem Pharmacol 2010, 79:722-732.
266. Schmielau J., Finn O.J. Activated Granulocytes and Granulocyte-Derived Hydrogen Peroxide Are the Underlying Mechanism of Suppression of T-Cell Function in Advanced Cancer Patients. Cancer Res 2001, 61:4756-4760.
267. Schopfer F.J., Baker P.R., Freeman B.A. NO-Dependent Protein Nitration: A Cell Signaling Event or an Oxidative Inflammatory Response?. Trends Biochem Sci 2003, 28:646-654.
268. Scott D.J., Hull M.A., Cartwright E.J., Lam W.K., Tisbury A., Poulsom R., et al. Lack of Inducible Nitric Oxide Synthase Promotes Intestinal Tumorigenesis in the Apc(Min/+) Mouse. Gastroenterology 2001, 121:889-899.
269. Semenza G.L. HIF-1 and Mechanisms of Hypoxia Sensing. Curr Opin Cell Biol 2001, 13:167-171.
270. Semenza G.L. Targeting HIF-1 for Cancer Therapy. Nat Rev Cancer 2003, 3:721-732.
271. Serafini P., Borrello I., Bronte V. Myeloid Suppressor Cells in Cancer: Recruitment, Phenotype, Properties, and Mechanisms of Immune Suppression. Semin Cancer Biol 2006, 16:53-65.
272. Serafini P., De Santo C., Marigo I., Cingarlini S., Dolcetti L., Gallina G., et al. Derangement of Immune Responses by Myeloid Suppressor Cells. Cancer Immunol Immunother 2004, 53:64-72.
273. + T Cell Homeostasis. J Immunol 2006, 176:735-739.
274. Sharara A.I., Perkins D.J., Misukonis M.A., Chan S.U., Dominitz J.A., Weinberg J.B. Interferon (IFN)-Alpha Activation of Human Blood Mononuclear Cells in Vitro and in Vivo for Nitric Oxide Synthase (NOS) Type 2 mRNA and Protein Expression: Possible Relationship of Induced NOS2 to the Anti-Hepatitis C Effects of IFN-Alpha in Vivo. J Exp Med 1997, 186:1495-1502.
275. Sharda D.R., Yu S., Ray M., Squadrito M.L., De Palma M., Wynn T.A., et al. Regulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase. J Immunol 2011, 187:2181-2192.
276. Shi O., Morris S.M., Zoghbi H., Porter C.W., O'Brien W.E. Generation of a Mouse Model for Arginase II Deficiency by Targeted Disruption of the Arginase II Gene. Mol Cell Biol 2001, 21:811-813.
277. Shi Q., Xiong Q., Wang B., Le X., Khan N.A., Xie K. Influence of Nitric Oxide Synthase II Gene Disruption on Tumor Growth and Metastasis. Cancer Res 2000, 60:2579-2583.
278. Shinoda J., McLaughlin K.E., Bell H.S., Swaroop G.R., Yamaguchi S., Holmes M.C., et al. Molecular Mechanisms Underlying Dexamethasone Inhibition of iNOS Expression and Activity in C6 Glioma Cells. Glia 2003, 42:68-76.
279. Sica A., Bronte V. Altered Macrophage Differentiation and Immune Dysfunction in Tumor Development. J Clin Invest 2007, 117:1155-1166.
280. Siegert A., Rosenberg C., Schmitt W.D., Denkert C., Hauptmann S. Nitric Oxide of Human Colorectal Adenocarcinoma Cell Lines Promotes Tumour Cell Invasion. Br J Cancer 2002, 86:1310-1315.
281. Singh R., Pervin S., Karimi A., Cederbaum S., Chaudhuri G. Arginase Activity in Human Breast Cancer Cell Lines: N(Omega)-Hydroxy-L-Arginine Selectively Inhibits Cell Proliferation and Induces Apoptosis in MDA-MB-468 Cells. Cancer Res 2000, 60:3305-3312.
282. Singh S., Gupta A.K. Nitric Oxide: Role in Tumour Biology and iNOS/NO-Based Anticancer Therapies. Cancer Chemother Pharmacol 2011, 67:1211-1224.
283. Sinha P., Clements V., Ostrand-Rosenberg S. Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease. J Immunol 2005, 174:636-645.
284. Sinha P., Clements V.K., Fulton A.M., Ostrand-Rosenberg S. Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells. Cancer Res 2007, 67:4507-4513.
285. Solito S., Falisi E., Diaz-Montero C.M., Doni A., Pinton L., Rosato A., et al. Human Promyelocytic-Like Population Is Responsible for the Immune Suppression Mediated by Myeloid-Derived Suppressor Cells. Blood 2011, 118:2254-2265.
286. Sonoki T., Nagasaki A., Gotoh T., Takiguchi M., Takeya M., Matsuzaki H., et al. Coinduction of Nitric-Oxide Synthase and Arginase I in Cultured Rat Peritoneal Macrophages and Rat Tissues in Vivo by Lipopolysaccharide. J Biol Chem 1997, 272:3689-3693.
287. Sousa M.S., Latini F.R., Monteiro H.P., Cerutti J.M. Arginase 2 and Nitric Oxide Synthase: Pathways Associated with the Pathogenesis of Thyroid Tumors. Free Radic Biol Med 2010, 49:997-1007.
288. Suarez-Pinzon W.L., Mabley J.G., Strynadka K., Power R.F., Szabo C., Rabinovitch A. An Inhibitor of Inducible Nitric Oxide Synthase and Scavenger of Peroxynitrite Prevents Diabetes Development in NOD Mice. J Autoimmun 2001, 16:449-455.
289. Suarez-Pinzon W.L., Szabo C., Rabinovitch A. Development of Autoimmune Diabetes in Nod Mice Is Associated with the Formation of Peroxynitrite in Pancreatic Islet Beta-Cells. Diabetes 1997, 46:907-911.
290. Suer Gokmen S., Yoruk Y., Cakir E., Yorulmaz F., Gulen S. Arginase and Ornithine, as Markers in Human Non-Small Cell Lung Carcinoma. Cancer Biochem Biophys 1999, 17:125-131.
291. Swana H.S., Smith S.D., Perrotta P.L., Saito N., Wheeler M.A., Weiss R.M. Inducible Nitric Oxide Synthase with Transitional Cell Carcinoma of the Bladder. J Urol 1999, 161:630-634.
292. Talmadge J.E., Hood K.C., Zobel L.C., Shafer L.R., Coles M., Toth B. Chemoprevention by Cyclooxygenase-2 Inhibition Reduces Immature Myeloid Suppressor Cell Expansion. Int Immunopharmacol 2007, 7:140-151.
293. Tatemichi M., Sawa T., Gilibert I., Tazawa H., Katoh T., Ohshima H. Increased Risk of Intestinal Type of Gastric Adenocarcinoma in Japanese Women Associated with Long Forms of CCTTT Pentanucleotide Repeat in the Inducible Nitric Oxide Synthase Promoter. Cancer Lett 2005, 217:197-202.
294. Tatemichi M., Tazawa H., Masuda M., Saleem M., Wada S., Donehower L.A., et al. Suppression of Thymic Lymphomas and Increased Nonthymic Lymphomagenesis in Trp53-Deficient Mice Lacking Inducible Nitric Oxide Synthase Gene. Int J Cancer 2004, 111:819-828.
295. Terrazas L.I., Walsh K.L., Piskorska D., McGuire E., Harn D.A. The Schistosome Oligosaccharide Lacto-N-Neotetraose Expands Gr1(+) Cells That Secrete Anti-Inflammatory Cytokines and Inhibit Proliferation of Naive CD4(+) Cells: A Potential Mechanism for Immune Polarization in Helminth Infections. J Immunol 2001, 167:5294-5303.
296. Tesei A., Ricotti L., Ulivi P., Medri L., Amadori D., Zoli W. Ncx 4016, a Nitric Oxide-Releasing Aspirin Derivative, Exhibits a Significant Antiproliferative Effect and Alters Cell Cycle Progression in Human Colon Adenocarcinoma Cell Lines. Int J Oncol 2003, 22:1297-1302.
297. Thengchaisri N., Hein T.W., Wang W., Xu X., Li Z., Fossum T.W., et al. Upregulation of Arginase by H2o2 Impairs Endothelium-Dependent Nitric Oxide-Mediated Dilation of Coronary Arterioles. Arterioscler Thromb Vasc Biol 2006.
298. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., Moncada S. Nitric Oxide Synthase Activity in Human Gynecological Cancer. Cancer Res 1994, 54:1352-1354.
299. Thomsen L.L., Miles D.W. Role of Nitric Oxide in Tumour Progression: Lessons from Human Tumours. Cancer Metastasis Rev 1998, 17:107-118.
300. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Nitric Oxide Synthase Activity in Human Breast Cancer. Br J Cancer 1995, 72:41-44.
301. Thoren F.B., Betten A., Romero A.I., Hellstrand K. Cutting Edge: Antioxidative Properties of Myeloid Dendritic Cells: Protection of T Cells and NK Cells from Oxygen Radical-Induced Inactivation and Apoptosis. J Immunol 2007, 179:21-25.
302. bright Subset of Nk Cells Is Resistant to Oxidant-Induced Cell Death. J Immunol 2007, 179:781-785.
303. Thun M.J., Henley S.J., Patrono C. Nonsteroidal Anti-Inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues. J Natl Cancer Inst 2002, 94:252-266.
304. Torrens I., Mendoza O., Batte A., Reyes O., Fernandez L.E., Mesa C., et al. Immunotherapy with Ctl Peptide and Vssp Eradicated Established Human Papillomavirus (HPV) Type 16 E7-Expressing Tumors. Vaccine 2005, 23:5768-5774.
305. Vakkala M., Kahlos K., Lakari E., Paakko P., Kinnula V., Soini Y. Inducible Nitric Oxide Synthase Expression, Apoptosis, and Angiogenesis in in Situ and Invasive Breast Carcinomas. Clin Cancer Res 2000, 6:2408-2416.
306. Veltman J.D., Lambers M.E., van Nimwegen M., Hendriks R.W., Hoogsteden H.C., Aerts J.G., et al. COX-2 Inhibition Improves Immunotherapy and Is Associated with Decreased Numbers of Myeloid-Derived Suppressor Cells in Mesothelioma. Celecoxib Influences Mdsc Function. BMC Cancer 2010, 10:464.
307. Vickers S.M., MacMillan-Crow L.A., Green M., Ellis C., Thompson J.A. Association of Increased Immunostaining for Inducible Nitric Oxide Synthase and Nitrotyrosine with Fibroblast Growth Factor Transformation in Pancreatic Cancer. Arch Surg 1999, 134:245-251.
308. Vig M., Srivastava S., Kandpal U., Sade H., Lewis V., Sarin A., et al. Inducible Nitric Oxide Synthase in T Cells Regulates T Cell Death and Immune Memory. J Clin Invest 2004, 113:1734-1742.
309. Villalta F., Zhang Y., Bibb K.E., Kappes J.C., Lima M.F. The Cysteine-Cysteine Family of Chemokines Rantes, MIP-1alpha, and MIP-1beta Induce Trypanocidal Activity in Human Macrophages Via Nitric Oxide. Infect Immun 1998, 66:4690-4695.
310. Vincendeau P., Gobert A.P., Daulouede S., Moynet D., Djavad Mossalayi M. Arginases in Parasitic Diseases. Trends Parasitol 2003, 19:9-12.
311. Vouldoukis I., Riveros-Moreno V., Dugas B., Ouaaz F., Becherel P., Debre P., et al. The Killing of Leishmania Major by Human Macrophages Is Mediated by Nitric Oxide Induced after Ligation of the Fc Epsilon RII/CD23 Surface Antigen. Proc Natl Acad Sci U S A 1995, 92:7804-7808.
312. Wallace J.L., Ignarro L.J., Fiorucci S. Potential Cardioprotective Actions of No-Releasing Aspirin. Nat Rev Drug Discov 2002, 1:375-382.
313. Wang B., Xiong Q., Shi Q., Le X., Abbruzzese J.L., Xie K. Intact Nitric Oxide Synthase Ii Gene Is Required for Interferon-Beta-Mediated Suppression of Growth and Metastasis of Pancreatic Adenocarcinoma. Cancer Res 2001, 61:71-75.
314. Wang X., Zhao Q., Matta R., Meng X., Liu X., Liu C.G., et al. Inducible Nitric-Oxide Synthase Expression Is Regulated by Mitogen-Activated Protein Kinase Phosphatase-1. J Biol Chem 2009, 284:27123-27134.
315. Wei D., Richardson E.L., Zhu K., Wang L., Le X., He Y., et al. Direct Demonstration of Negative Regulation of Tumor Growth and Metastasis by Host-Inducible Nitric Oxide Synthase. Cancer Res 2003, 63:3855-3859.
316. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., et al. Altered Immune Responses in Mice Lacking Inducible Nitric Oxide Synthase. Nature 1995, 375:408-411.
317. Weigert A., Brune B. Nitric Oxide, Apoptosis and Macrophage Polarization During Tumor Progression. Nitric Oxide 2008, 19:95-102.
318. Weinberg J.B. Nitric Oxide Production and Nitric Oxide Synthase Type 2 Expression by Human Mononuclear Phagocytes: A Review. Mol Med 1998, 4:557-591.
319. Weiss J.M., Back T.C., Scarzello A.J., Subleski J.J., Hall V.L., Stauffer J.K., et al. Successful Immunotherapy with IL-2/Anti-CD40 Induces the Chemokine-Mediated Mitigation of an Immunosuppressive Tumor Microenvironment. Proc Natl Acad Sci U S A 2009, 106:19455-19460.
320. Weiss J.M., Ridnour L.A., Back T., Hussain S.P., He P., Maciag A.E., et al. Macrophage-Dependent Nitric Oxide Expression Regulates Tumor Cell Detachment and Metastasis after IL-2/Anti-CD40 Immunotherapy. J Exp Med 2010, 207:2455-2467.
321. Weisser S.B., McLarren K.W., Voglmaier N., van Netten-Thomas C.J., Antov A., Flavell R.A., et al. Alternative Activation of Macrophages by IL-4 Requires SHIP Degradation. Eur J Immunol 2011, 41:1742-1753.
322. Weninger W., Rendl M., Pammer J., Mildner M., Tschugguel W., Schneeberger C., et al. Nitric Oxide Synthases in Kaposi's Sarcoma Are Expressed Predominantly by Vessels and Tissue Macrophages. Lab Invest 1998, 78:949-955.
323. West M.B., Hill B.G., Xuan Y.T., Bhatnagar A. Protein Glutathiolation by Nitric Oxide: An Intracellular Mechanism Regulating Redox Protein Modification. FASEB J 2006, 20:1715-1717.
324. Williams J.L., Kashfi K., Ouyang N., del Soldato P., Kopelovich L., Rigas B. No-Donating Aspirin Inhibits Intestinal Carcinogenesis in Min (Apc(Min/+)) Mice. Biochem Biophys Res Commun 2004, 313:784-788.
325. Wilson K.T., Fu S., Ramanujam K.S., Meltzer S.J. Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett's Esophagus and Associated Adenocarcinomas. Cancer Res 1998, 58:2929-2934.
326. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The Multifaceted Roles of Nitric Oxide in Cancer. Carcinogenesis 1998, 19:711-721.
327. Witherell H.L., Hiatt R.A., Replogle M., Parsonnet J. Helicobacter Pylori Infection and Urinary Excretion of 8-Hydroxy-2-Deoxyguanosine, an Oxidative DNA Adduct. Cancer Epidemiol Biomarkers Prev 1998, 7:91-96.
328. Wu C.W., Chung W.W., Chi C.W., Kao H.L., Lui W.Y., P'Eng F.K., et al. Immunohistochemical Study of Arginase in Cancer of the Stomach. Virchows Arch 1996, 428:325-331.
329. Wu G., Morris S.M. Arginine Metabolism: Nitric Oxide and Beyond. Biochem J 1998, 336(Pt 1):1-17.
330. Xia Y., Roman L.J., Masters B.S., Zweier J.L. Inducible Nitric-Oxide Synthase Generates Superoxide from the Reductase Domain. J Biol Chem 1998, 273:22635-22639.
331. Xia Y., Zweier J.L. Superoxide and Peroxynitrite Generation from Inducible Nitric Oxide Synthase in Macrophages. Proc Natl Acad Sci U S A 1997, 94:6954-6958.
332. Xie Q.W., Kashiwabara Y., Nathan C. Role of Transcription Factor NF-Kappa B/Rel in Induction of Nitric Oxide Synthase. J Biol Chem 1994, 269:4705-4708.
333. Zabaleta J., McGee D.J., Zea A.H., Hernandez C.P., Rodriguez P.C., Sierra R.A., et al. Helicobacter Pylori Arginase Inhibits T Cell Proliferation and Reduces the Expression of the Tcr Zeta-Chain (CD3zeta). J Immunol 2004, 173:586-593.
334. Zea A.H., Culotta K.S., Ali J., Mason C., Park H.J., Zabaleta J., et al. Decreased Expression of CD3zeta and Nuclear Transcription Factor Kappa B in Patients with Pulmonary Tuberculosis: Potential Mechanisms and Reversibility with Treatment. J Infect Dis 2006, 194:1385-1393.
335. Zea A.H., Rodriguez P.C., Atkins M.B., Hernandez C., Signoretti S., Zabaleta J., et al. Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion. Cancer Res 2005, 65:3044-3048.
336. Zhu W., Chandrasekharan U.M., Bandyopadhyay S., Morris S.M., DiCorleto P.E., Kashyap V.S. Thrombin Induces Endothelial Arginase through AP-1 Activation. Am J Physiol Cell Physiol 2010, 298:C952-C960.
337. Ziche M., Morbidelli L., Choudhuri R., Zhang H.T., Donnini S., Granger H.J., et al. Nitric Oxide Synthase Lies Downstream from Vascular Endothelial Growth Factor-Induced but Not Basic Fibroblast Growth Factor-Induced Angiogenesis. J Clin Invest 1997, 99:2625-2634.